Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sho Ueno"'
Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
Publikováno v:
Pharmaceutics, Vol 12, Iss 6, p 585 (2020)
ErbB2 is a type of receptor tyrosine kinase, which is known to be involved in tumorigenesis, tumor aggressiveness, and clinical outcome. ErbB2-targeting therapy using therapeutic antibodies has been successful in breast cancer treatment. However, the
Externí odkaz:
https://doaj.org/article/1e9274b2aff14c67b9781e1c149589fb
Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
Publikováno v:
Pharmaceutics, Vol 12, Iss 585, p 585 (2020)
Pharmaceutics
Volume 12
Issue 6
Pharmaceutics
Volume 12
Issue 6
ErbB2 is a type of receptor tyrosine kinase, which is known to be involved in tumorigenesis, tumor aggressiveness, and clinical outcome. ErbB2-targeting therapy using therapeutic antibodies has been successful in breast cancer treatment. However, the
Autor:
Ho-Chol Chang, Akira Nakayama, Sho Ueno, Atsushi Kobayashi, Takeshi Matsumoto, Tetsuya Taketsugu, Masanori Wakizaka, Masako Kato
Publikováno v:
Journal of the American Chemical Society. 135(23)
The combination of o-phenylenediamine (opda), which possesses two proton- and electron-pooling capability, with Fe(II) leads to the photochemical hydrogen-evolution reaction (HER) in THF at room temperature without addition of photosensitizers. From
Autor:
Matsumoto, Takeshi, Ho-Chol Chang, Wakizaka, Masanori, Sho Ueno, Kobayashi, Atsushi, Nakayama, Akira, Taketsugu, Tetsuya, Kato, Masako
Publikováno v:
Journal of the American Chemical Society; 6/12/2013, Vol. 135 Issue 23, p8646-8654, 9p